Company Filing History:
Years Active: 2001
Title: John M Morin: Innovator in Indole Compounds
Introduction
John M Morin is a notable inventor based in Brownsburg, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs for therapeutic applications. His work focuses on enhancing the bioavailability of compounds used in medical treatments.
Latest Patents
John M Morin holds a patent for "Morpholino-N-ethyl ester prodrugs of indole sPLA2 inhibitors." The compound, specifically ((3(2-amino-1,2-dioxoethyl)-1-((1,1′-biphenyl)-3-ylmethyl)-2-methyl-1H-indol-4-yl)oxy)acetic acid morpholino-ethyl ester, is designed to be a highly bioavailable indole compound. This compound is intended for inhibiting sPLA2-mediated release of fatty acids, which can be crucial in treating conditions such as septic shock. He has 1 patent to his name.
Career Highlights
John M Morin is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at the company has contributed to advancements in drug formulations and therapeutic strategies.
Collaborations
Throughout his career, John has collaborated with notable colleagues, including Michael Lyle Denney and Daniel Jon Sall. These collaborations have likely enhanced the scope and impact of his research efforts.
Conclusion
John M Morin is a distinguished inventor whose work in indole compounds has the potential to significantly impact medical treatments. His contributions to the field exemplify the importance of innovation in pharmaceuticals.